Report From the NEI/FDA Endpoints Workshop on Age-Related Macular Degeneration and Inherited Retinal Diseases

Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3456-3463. doi: 10.1167/iovs.17-22339.

Authors

Karl Csaky¹, Frederick Ferris 3rd², Emily Y Chew², Prashant Nair³, Janet K Cheetham⁴, Jacque L Duncan⁵

Affiliations

¹ Retina Foundation of the Southwest, Dallas, Texas, United States.
² National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
³ Washington, District of Columbia, United States.
⁴ Foundation Fighting Blindness, Laguna Niguel, California, United States.
⁵ Department of Ophthalmology, University of California, San Francisco, California, United States.

No abstract available

Publication types

Congress

MeSH terms

Clinical Trials as Topic / methods*
Endpoint Determination*
Geographic Atrophy / therapy
Humans
Macular Degeneration / therapy
Retinal Diseases / physiopathology
Retinal Diseases / therapy*
Visual Acuity / physiology
Visual Fields / physiology